Blood Cancer Clinical Trial
Official title:
A Phase 1, Dose-escalation Study of MEDI-551, a Humanized Monoclonal Antibody Directed Against CD19, in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
The primary objective of this study is to evaluate the safety and tolerability of MEDI-551 in Japanese patients with relapsed or refractory advanced B-cell malignancies.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
| Not yet recruiting |
NCT06455592 -
Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years
|
N/A | |
| Completed |
NCT03654404 -
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients
|
N/A | |
| Recruiting |
NCT06116032 -
Immune Profiling for Cancer Immunotherapy Response
|
||
| Recruiting |
NCT04955938 -
A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms
|
Phase 1 | |
| Recruiting |
NCT06119685 -
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05391490 -
Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
|
Phase 1 | |
| Not yet recruiting |
NCT06469307 -
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
|
||
| Recruiting |
NCT05709522 -
Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
|
||
| Completed |
NCT00186225 -
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
|
N/A | |
| Active, not recruiting |
NCT05147311 -
Positive Psychology Intervention In HSCT
|
N/A | |
| Recruiting |
NCT04372524 -
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
|
||
| Completed |
NCT00185640 -
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies
|
Phase 2 | |
| Withdrawn |
NCT04390542 -
Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy
|
N/A | |
| Completed |
NCT04419623 -
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer
|
Phase 1 | |
| Recruiting |
NCT04806295 -
The Leukemia and Lymphoma Society (LLS) National Research Registry
|
||
| Recruiting |
NCT05873205 -
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
|
Phase 2 | |
| Completed |
NCT00962494 -
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
|
Phase 2 | |
| Completed |
NCT00185796 -
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
|
Phase 2 | |
| Completed |
NCT04236063 -
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
|